SCHEMBL30711802

SCHEMBL30711802

CN(C)CCNCc1ccc2cc(F)cc(NC(=O)OC(C)(C)C)c2n1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 3/20 0.40
SIGMAR1 Q99720 3/20 0.40
TERT O14746 1/20 0.37
KCNQ4 P56696 3/20 0.37
KCNQ5 Q9NR82 3/20 0.37
ATM Q13315 1/20 0.35
MAP4K4 O95819 1/20 0.34
CYP17A1 P05093 1/20 0.34
MOK Q9UQ07 1/20 0.33
BRAF P15056 1/20 0.32
MAPKAPK2 P49137 2/20 0.32
CKS1B P61024 1/20 0.32
SKP1 P63208 1/20 0.32
SKP2 Q13309 1/20 0.32
TACR1 P25103 1/20 0.32
CCR2 P41597 1/20 0.32
MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20838489 1.00 TMEM97 (0.40) TMEM97SIGMAR1TERTKCNQ4KCNQ5
SCHEMBL20838468 0.82 MAPKAPK2 (0.34) TMEM97SIGMAR1TERTATMMOK
SCHEMBL20853406 0.80 LCK (0.37) SIGMAR1TERTATMMAPKAPK2CKS1B
SCHEMBL20853401 0.77 CYP17A1 (0.40) KCNQ4KCNQ5CYP17A1BRAF
SCHEMBL30711774 0.77 CYP17A1 (0.40) KCNQ4KCNQ5CYP17A1BRAF
SCHEMBL20838488 0.76 TERT (0.38) TMEM97SIGMAR1TERTMAP4K4MOK
SCHEMBL20838475 0.76 MOK (0.39) TMEM97SIGMAR1TERTMOKTACR1
SCHEMBL20882035 0.76 CYP17A1 (0.38) KCNQ4KCNQ5CYP17A1BRAFMAPKAPK2
SCHEMBL30711791 0.76 CYP17A1 (0.38) KCNQ4KCNQ5CYP17A1BRAFMAPKAPK2
SCHEMBL1507944 0.74 PLAU (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3466931-B1 TETRADENTATE CHELATING MONOQUINOLINE DERIVATIVE, MANUFACTURING METHOD THEREOF, AND APPLICATION OF SAME AS METAL ION REGULATOR FOR NEURODEGENERATIVE DISEASE UNIV GUANGDONG TECHNOLOGY (CN) 2024-01-10 EP disclosed